Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
37912
CAS Number:
93479-97-1
Glimépiride
Grade:
Conforme aux spécifications USP
Purity:
98 - 102 % (dosage sur une base anhydre)
Documents
$60.00 /1G
Taille
Request Bulk Quote
Informations sur le produit

Glimepiride is a potent sulfonylurea antidiabetic agent widely utilized in the management of type 2 diabetes mellitus. This compound functions by stimulating insulin secretion from pancreatic beta cells, thereby effectively lowering blood glucose levels. Its unique mechanism of action not only enhances insulin sensitivity but also reduces hepatic glucose production, making it a valuable option for patients who require glycemic control. Glimepiride is often prescribed in combination with other antidiabetic medications, providing a synergistic effect that can lead to improved patient outcomes.

In addition to its primary use in diabetes management, Glimepiride has shown potential in research settings for exploring new therapeutic avenues in metabolic disorders. Its favorable pharmacokinetic profile allows for once-daily dosing, enhancing patient compliance. With its established efficacy and safety profile, Glimepiride remains a cornerstone in diabetes treatment protocols, offering healthcare professionals a reliable tool for managing this chronic condition.

Numéro CAS 
93479-97-1
Formule moléculaire
C24H34N4O5S
Poids moléculaire 
490.62
Point de fusion 
202 - 206 °C (lit.)
Informations générales
Numéro CAS 
93479-97-1
Formule moléculaire
C24H34N4O5S
Poids moléculaire 
490.62
Point de fusion 
202 - 206 °C (lit.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Glimepiride is widely utilized in research focused on

  • Diabetes Management: Primarily used to treat type 2 diabetes, it helps lower blood sugar levels effectively, making it a critical medication for patients managing this condition.
  • Pharmaceutical Development: Researchers are exploring its combination with other antidiabetic agents to enhance efficacy and reduce side effects, which can lead to more effective treatment regimens.
  • Clinical Studies: It is frequently included in clinical trials aimed at understanding its long-term effects and interactions with other medications, providing valuable data for healthcare professionals.
  • Patient Compliance: Its once-daily dosing schedule improves adherence to treatment plans, which is crucial for maintaining stable blood sugar levels in patients.
  • Cost-Effectiveness: Compared to other diabetes medications, Glimepiride is often more affordable, making it accessible for a broader range of patients, particularly in low-income settings.

Citations